Lisinopril and Hydrochlorthiazide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Lisinopril and Hydrochlorthiazide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING



LISINOPRIL AND HYDROCHLORTHIAZIDE DESCRIPTION



Lisinopril and Hydrochlorthiazide




Lisinopril and Hydrochlorthiazide





CLINICAL PHARMACOLOGY

Lisinopril and Hydrochlorothiazide





Lisinopril

Mechanism of Action




Pharmacokinetics and Metabolism






Pharmacodynamics







Hydrochlorothiazide





INDICATIONS & USAGE






LISINOPRIL AND HYDROCHLORTHIAZIDE CONTRAINDICATIONS



WARNINGS

General

Lisinopril




















Hydrochlorothiazide






Pregnancy

Lisinopril and Hydrochlorothiazide



Lisinopril









Hydrochlorothiazide


PRECAUTIONS

General

Lisinopril














Hydrochlorothiazide












Information for Patients












Drug Interactions

Lisinopril















Hydrochlorothiazide




















Carcinogenesis, Mutagenesis, Impairment of Fertility

Lisinopril and Hydrochlorothiazide


Lisinopril




Hydrochlorothiazide




Pregnancy


Nursing Mothers


Pediatric Use


Geriatric Use



LISINOPRIL AND HYDROCHLORTHIAZIDE ADVERSE REACTIONS































Clinical Laboratory Test Findings












Lisinopril




























Hydrochlorothiazide



















OVERDOSAGE



DOSAGE & ADMINISTRATION










HOW SUPPLIED
















PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Lisinopril and Hydrochlorthiazide



Lisinopril and Hydrochlorthiazide






Lisinopril and Hydrochlorthiazide

Lisinopril and Hydrochlorthiazide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-129(NDC:60505-0207-3)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
LISINOPRIL LISINOPRIL ANHYDROUS 20 mg
HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE 25 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
pink 10 mm APO;20;25 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-129-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076674 2011-04-04


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.